Maria Carla Roncaglioni

Researcher
Department of Cardiovascular Research
Negri Institute for Pharmacological Research
Italy

Academician Cardiology
Biography

Maria Carla Roncaglioni, Biol.Sci.D. in 1987 Doctoral degree in Biological Sciences, University of Milan, Italy. 1982-1983 Research Fellow at the Dept. of Biochemistry, Faculty of Medicine, Rijksuniversiteit of Limburg, Maastricht. 1998-1999 Visiting Scientist at the Cardiovascular Research Unit, Hammersmith Hospital, London, UK. 2001 Head of the Laboratory of Cardiovascular Prevention 1999-2000 Senior Researcher, Clinical Pharmacology Laboratory. 1974-1987 Researcher, Laboratory for the Study of Haemostasis and Thrombosis.

Research Intrest

In particular, current research ongoing are focused on the optimization of cardiovascular prevention in high-risk individuals, on lifestyles improvement, on the prevention of stroke in patients with atrial fibrillation and on the adherence to drug therapy using the polypill strategy for secondary prevention of myocardial infarction. A part of the activity is devoted to drug-epidemiology and rational use of drugs, based on prescriptions, hospitalizations and outpatient of large administrative data-base analyses.

List of Publications
Marzona I, Avanzini F, Lucisano G, Tettamanti M, Baviera M, Nicolucci A, Roncaglioni M C, Risk and Prevention Collaborative Group Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study. Acta Diabetol E-pub: (2016) IF: 3.074
Avanzini F, Marzona I, Baviera M, Barlera S, Milani V, Caimi V, Longoni P, Tombesi M, Silletta M G, Tognoni G, Roncaglioni M C, Risk and Prevention Study Collaborative Group Improving cardiovascular prevention in general practice: Results of a comprehensive personalized strategy in subjects at high risk.Eur J Prev Cardiol 23: 947-955 (2016) IF: 3.361
Avanzini F, Marelli G, Saltafossi D, Longhi C, Carbone S, Carlino L, Planca E, Vilei V, Roncaglioni M C, Riva E, DDD Study Group Effectiveness, safety and feasibility of an evidence-based insulin infusion protocol targeting moderate glycaemic control in intensive cardiac care units. Eur Heart J Acute Cardiovasc Care 5: 117-124 (2016)